{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:23:32Z","timestamp":1794349412549,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.isci.2026.117631","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:46:55Z","timestamp":1790448415000},"page":"117631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human lung explants as a predictive platform for evaluating the on-target, off-tumor toxicity of T cell bispecifics"],"prefix":"10.1016","volume":"29","author":[{"given":"Manuel","family":"Tschan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Jetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Obenloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-9313","authenticated-orcid":false,"given":"Nitya","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauriane","family":"Cabon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"D\u2019Arcangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-305X","authenticated-orcid":false,"given":"Matthias P.","family":"Lutolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117631_bib1","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.ymthe.2024.07.028","article-title":"T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting","volume":"32","author":"Anderson","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.117631_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41416-025-03125-y","article-title":"T cell engagers: expanding horizons in oncology and beyond","volume":"133","author":"Albayrak","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.117631_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-023-01482-w","article-title":"Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies","volume":"16","author":"Tapia-Galisteo","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.117631_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112609","article-title":"Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors","volume":"138","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.117631_bib5","article-title":"Exploring T-cell bispecific antibodies in gynecologic malignancy","volume":"59","author":"O\u2019Brien","year":"2025","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.isci.2026.117631_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-021-01067-5","article-title":"CAR-T cells and BiTEs in solid tumors: challenges and perspectives","volume":"14","author":"Edeline","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.117631_bib7","article-title":"A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM\/CD3 T-cell engager (BiTE\u00ae) antibody construct, in patients with refractory solid tumors","volume":"7","author":"Kebenko","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2026.117631_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67106","article-title":"Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies","volume":"10","author":"Kerns","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.117631_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41416-019-0672-6","article-title":"Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery","volume":"122","author":"Powley","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.117631_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.976065","article-title":"Patient-derived cancer models: Valuable platforms for anticancer drug testing","volume":"12","author":"Genta","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117631_bib11","doi-asserted-by":"crossref","DOI":"10.4155\/fsoa-2017-0003","article-title":"Ex vivo tumor culture systems for functional drug testing and therapy response prediction","volume":"3","author":"Meijer","year":"2017","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.isci.2026.117631_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41420-021-00651-5","article-title":"Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition","volume":"7","author":"Junk","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.isci.2026.117631_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2466305","article-title":"Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses","volume":"14","author":"Turpin","year":"2025","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2026.117631_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.611365","article-title":"Explant Modeling of the Immune Environment of Head and Neck Cancer","volume":"11","author":"Sharon","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117631_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.767697","article-title":"Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management","volume":"11","author":"Templeton","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117631_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-016-2119-2","article-title":"Tumor slice culture system to assess drug response of primary breast cancer","volume":"16","author":"Naipal","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.117631_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.2013.700","article-title":"Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance","volume":"110","author":"Gerlach","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.117631_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63170-0","article-title":"An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy","volume":"14","author":"Demetriou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117631_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s43018-021-00325-2","article-title":"Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer","volume":"3","author":"Gavert","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.117631_bib20","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","article-title":"An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer","volume":"27","author":"Voabil","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117631_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn9440","article-title":"Immunotherapy of glioblastoma explants induces interferon-\u03b3 responses and spatial immune cell rearrangements in tumor center, but not periphery","volume":"8","author":"Shekarian","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.117631_bib22","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.tibtech.2025.07.020","article-title":"Extended human lymph node explants for evaluation of adaptive immunity","volume":"43","author":"Fernando","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.isci.2026.117631_bib23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00262-020-02828-w","article-title":"Immunotherapy response modeling by ex-vivo organ culture for lung cancer","volume":"70","author":"Kamer","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2026.117631_bib24","article-title":"Reinvigoration of translational activity in dysfunctional T cells initiates the early intratumoral response to PD-1 blockade","author":"Kaptein","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.117631_bib25","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0016-5085(78)90701-1","article-title":"Explant culture of human colon","volume":"74","author":"Autrup","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.117631_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp0451","article-title":"Prolonged airway explant culture enables study of health, disease, and viral pathogenesis","volume":"11","author":"Lee-Ferris","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.117631_bib27","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.3390\/cancers13184596","article-title":"CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies","volume":"13","author":"Kauer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.117631_bib28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.4049\/jimmunol.1701532","article-title":"Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection","volume":"200","author":"Kiniry","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117631_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1392535","article-title":"Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials","volume":"15","author":"Thompson","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117631_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00441-012-1549-7","article-title":"Granzyme B-dependent and perforin-independent DNA fragmentation in intestinal epithelial cells induced by anti-CD3 mAb-activated intra-epithelial lymphocytes","volume":"352","author":"Ogata","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.isci.2026.117631_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)00140-9","article-title":"Mannose 6-Phosphate\/Insulin-like Growth Factor II Receptor Is a Death Receptor for Granzyme B during Cytotoxic T Cell\u2013Induced Apoptosis","volume":"103","author":"Motyka","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117631_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-5793(04)00187-5","article-title":"Killing of target cells by redirected granzyme B in the absence of perforin","volume":"562","author":"Kurschus","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.isci.2026.117631_bib33","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3390\/cancers12092644","article-title":"B Cells and Tertiary Lymphoid Structures Influence Survival in Lung Cancer Patients with Resectable Tumors","volume":"12","author":"Tang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.117631_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41435-025-00331-9","article-title":"The role of B cell immunity in lung adenocarcinoma","volume":"26","author":"Shu","year":"2025","journal-title":"Genes Immun."},{"key":"10.1016\/j.isci.2026.117631_bib35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41423-025-01285-8","article-title":"Activation and maturation of antigen-specific B cells in nonectopic lung infiltrates are independent of germinal center reactions in the draining lymph node","volume":"22","author":"Schacht","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.117631_bib36","article-title":"Mechanistic insights into resistance mechanisms to T cell engagers","volume":"16","author":"Cao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117631_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113494","article-title":"T cell-mediated curation and restructuring of tumor tissue coordinates an effective immune response","volume":"42","author":"Hickey","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117631_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106942","article-title":"T cell landscape in the microenvironment of human solid tumors","volume":"270","author":"Maggi","year":"2024","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.isci.2026.117631_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41577-023-00884-8","article-title":"Localization, tissue biology and T cell state \u2014 implications for cancer immunotherapy","volume":"23","author":"Schenkel","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117631_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1057","article-title":"Anatomical basis of tolerance and immunity to intestinal antigens","volume":"3","author":"Mowat","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117631_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 Challenges in Cancer Immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.117631_bib42","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/17460441.2025.2522088","article-title":"The impact of CD3 affinity-attenuation on T cell engaging bispecific antibodies: is it really that simple?","volume":"20","author":"Abdelmotaleb","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.isci.2026.117631_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.951","article-title":"Discriminating Between Apoptosis, Necrosis, Necroptosis, and Ferroptosis by Microscopy and Flow Cytometry","volume":"3","author":"Costigan","year":"2023","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.isci.2026.117631_bib44","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells","volume":"73","author":"Fink","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2026.117631_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/aor.14503","article-title":"FDA Modernization Act 2.0 allows for alternatives to animal testing","volume":"47","author":"Han","year":"2023","journal-title":"Artif. Organs"},{"key":"10.1016\/j.isci.2026.117631_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102282","article-title":"Protocol for ex vivo culture of patient-derived tumor fragments","volume":"4","author":"Roelofsen","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.isci.2026.117631_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41551-023-01156-5","article-title":"Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids","volume":"8","author":"Harter","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.isci.2026.117631_bib48","article-title":"High-throughput histopathology for complex in vitro models","author":"Harter","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.117631_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/path.6274","article-title":"Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy","volume":"263","author":"Li","year":"2024","journal-title":"J. Pathol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226030105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226030105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:40:12Z","timestamp":1794346812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226030105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589004226030105"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117631","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human lung explants as a predictive platform for evaluating the on-target, off-tumor toxicity of T cell bispecifics","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117631"}}